Investor
The company will use the funds to support and grow its team, enhance its platform and expand partnerships with payors, health systems and physicians.
Hyro will use the funds to expand its workforce, grow strategic partners and further build its platform.
The California-based company will use the funds to expand its oncology and surgical care-focused offerings.
Julien Pham, founder and managing partner of Third Culture Capital, discusses 3CC's quest to invest in founders from various backgrounds and help the companies prosper.
Dr. Jay Bhatt, managing director at Deloitte, warns that without high-quality algorithms technology has the potential to increase health inequities and drive mistrust.
The company is fighting to stay afloat amid growing losses and instability.
The company, cofounded by Tony Robbins and backed by Serena Williams, will use the funds to speed up growth and expand its offerings.
HIMSS23
Dr. Hans Kluge, regional director for Europe at WHO, discusses the need for collaboration between public health workers and technology vendors around the world to improve public trust and health equity.
The prescription digital therapeutics company's assets were sold to four bidders: Click Therapeutics, Harvest BIO, Nox Health Group and Welt.
It is now looking to expand into other regions such as the Middle East.